Literature DB >> 15012985

Orally active anti-proliferation agents: novel diphenylamine derivatives as FGF-R2 autophosphorylation inhibitors.

Toshiyuki Shimizu1, Yasunari Fujiwara, Tatsushi Osawa, Teruyuki Sakai, Kinya Kubo, Kazuo Kubo, Tsuyoshi Nishitoba, Kaname Kimura, Terufumi Senga, Hideko Murooka, Akemi Iwai, Kayoko Fukushima, Tetsuya Yoshino, Atsushi Miwa.   

Abstract

(6,7-Disubstituted-quinolin-4-yloxy-phenyl)(4-substituted-phenyl)amine derivatives were synthesized and evaluated by a cellular autophosphorylation assay for FGF-R2 in the human scirrhous gastric carcinoma cell line, OCUM-2MD3. We also performed metabolic stability studies showing that substitutions at the 7-position of quinoline affect its biological stability. In this study, we achieved a remarkable improvement in the solubility and metabolic stability of the diphenylamine derivative. The most promising compound 15e showed a significant decrease in tumor volume when orally administered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15012985     DOI: 10.1016/j.bmcl.2003.12.019

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Aryl Extensions of Thienopyrimidinones as Fibroblast Growth Factor Receptor 1 Kinase Inhibitors.

Authors:  Anil R Ekkati; Valsan Madiyan; Krishna P Ravindranathan; Jae H Bae; Joseph Schlessinger; William L Jorgensen
Journal:  Tetrahedron Lett       Date:  2011-04-27       Impact factor: 2.415

2.  Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts.

Authors:  Wei-meng Zhao; Lihong Wang; Hangil Park; Sophea Chhim; Melanie Tanphanich; Masakazu Yashiro; K Jin Kim
Journal:  Clin Cancer Res       Date:  2010-07-29       Impact factor: 12.531

Review 3.  Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.

Authors:  J C Becker; C Muller-Tidow; H Serve; W Domschke; T Pohle
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Cancer-stromal interactions in scirrhous gastric carcinoma.

Authors:  Masakazu Yashiro; Kosei Hirakawa
Journal:  Cancer Microenviron       Date:  2010-01-26

5.  Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model.

Authors:  M Yashiro; O Shinto; K Nakamura; M Tendo; T Matsuoka; T Matsuzaki; R Kaizaki; M Ohira; A Miwa; K Hirakawa
Journal:  Br J Cancer       Date:  2009-10-06       Impact factor: 7.640

6.  Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety.

Authors:  Murat Bingul; Owen Tan; Christopher R Gardner; Selina K Sutton; Greg M Arndt; Glenn M Marshall; Belamy B Cheung; Naresh Kumar; David StC Black
Journal:  Molecules       Date:  2016-07-14       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.